8.8754
price down icon0.86%   -0.0946
 
loading
Iteos Therapeutics Inc stock is traded at $8.8754, with a volume of 192.01K. It is down -0.86% in the last 24 hours and down -11.25% over the past month. ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
See More
Previous Close:
$8.97
Open:
$8.97
24h Volume:
192.01K
Relative Volume:
0.31
Market Cap:
$326.51M
Revenue:
$127.70M
Net Income/Loss:
$-108.14M
P/E Ratio:
-10.82
EPS:
-0.82
Net Cash Flow:
$-117.52M
1W Performance:
+3.64%
1M Performance:
-11.25%
6M Performance:
-23.73%
1Y Performance:
-14.00%
1-Day Range:
Value
$8.70
$9.11
1-Week Range:
Value
$8.41
$9.11
52-Week Range:
Value
$8.41
$18.75

Iteos Therapeutics Inc Stock (ITOS) Company Profile

Name
Name
Iteos Therapeutics Inc
Name
Phone
857-204-4583
Name
Address
321 ARSENAL STREET, WATERTOWN
Name
Employee
157
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
ITOS's Discussions on Twitter

Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades

Date Action Analyst Rating Change
May-05-21 Initiated H.C. Wainwright Buy
Oct-08-20 Initiated Robert W. Baird Outperform
Aug-18-20 Initiated JP Morgan Overweight
Aug-18-20 Initiated Piper Sandler Overweight
Aug-18-20 Initiated SVB Leerink Outperform
Aug-18-20 Initiated Wedbush Outperform
View All

Iteos Therapeutics Inc Stock (ITOS) Latest News

pulisher
Oct 30, 2024

Iteos Therapeutics stock hits 52-week low at $8.49 By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Iteos Therapeutics stock hits 52-week low at $8.49 - Investing.com

Oct 30, 2024
pulisher
Oct 24, 2024

iTeos Therapeutics präsentiert auf dem Immunonkologie-Kongress der ESMO präklinische und translationale Daten sowie Daten aus der klinischen Phase-II-Studie A2A-005 zu Inupadenant bei NSCLC in der Zweitlinie - GlobeNewswire Inc.

Oct 24, 2024
pulisher
Oct 24, 2024

iTeos Therapeutics to Highlight Inupadenant Preclinical, - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by nVerses Capital LLC - Defense World

Oct 24, 2024
pulisher
Oct 23, 2024

Iteos Therapeutics stock hits 52-week low at $8.73 - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

Iteos Therapeutics stock hits 52-week low at $8.73 By Investing.com - Investing.com Canada

Oct 23, 2024
pulisher
Oct 23, 2024

Exchange Traded Concepts LLC Sells 6,414 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

iTeos Looking At A Strong Finish To 2024 After Going From Fifth To First In TIGIT - Citeline

Oct 23, 2024
pulisher
Oct 22, 2024

(ITOS) Proactive Strategies - Stock Traders Daily

Oct 22, 2024
pulisher
Oct 16, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Position Decreased by AQR Capital Management LLC - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

BOXER CAPITAL, LLC Expands Stake in ITeos Therapeutics Inc - GuruFocus.com

Oct 16, 2024
pulisher
Oct 15, 2024

ITeos Therapeutics Inc (ITOS) shows promising results - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 9.73, Down by -2.21 - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

ITOS Stock on the Rise: A Promising Investment - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Millennium Management LLC Decreases Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Millennium Management LLC Lowers Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Oct 14, 2024
pulisher
Oct 12, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Update - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Squarepoint Ops LLC Sells 38,801 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

When (ITOS) Moves Investors should Listen - Stock Traders Daily

Oct 11, 2024
pulisher
Oct 11, 2024

Did ITeos Therapeutics Inc (ITOS) perform well in the last session? - US Post News

Oct 11, 2024
pulisher
Oct 11, 2024

Ratio Revelations: ITeos Therapeutics Inc (ITOS)’s Financial Metrics in the Spotlight - The Dwinnex

Oct 11, 2024
pulisher
Oct 07, 2024

TIGITs Trend Upward After iTeos/GSK Present Positive Data at ESMO - BioSpace

Oct 07, 2024
pulisher
Oct 06, 2024

Dimensional Fund Advisors LP Raises Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Oct 06, 2024
pulisher
Oct 04, 2024

ITeos TherapeuticsAssessing Breakthrough Therapies To Treat Cancer - RTTNews

Oct 04, 2024
pulisher
Oct 03, 2024

A new trading data show ITeos Therapeutics Inc (ITOS) is showing positive returns. - SETE News

Oct 03, 2024
pulisher
Oct 03, 2024

American Century Companies Inc. Has $687,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 03, 2024
pulisher
Oct 01, 2024

A closer look at ITeos Therapeutics Inc (ITOS)’s stock price trends - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Financial Metrics Exploration: Understanding ITeos Therapeutics Inc (ITOS) Through Ratios - The Dwinnex

Oct 01, 2024
pulisher
Oct 01, 2024

How the (ITOS) price action is used to our Advantage - Stock Traders Daily

Oct 01, 2024
pulisher
Sep 30, 2024

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in ITeos Therapeu - GuruFocus.com

Sep 30, 2024
pulisher
Sep 29, 2024

156,894 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Bought by Clearline Capital LP - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Clearline Capital LP Invests $2.33 Million in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

There is no way ITeos Therapeutics Inc (ITOS) can keep these numbers up - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

ESMO recap: Keeping TIGIT alive, Rybrevant & immunotherapy anniversary — a BioCentury podcast - BioCentury

Sep 25, 2024
pulisher
Sep 25, 2024

ITeos Therapeutics Inc (ITOS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

Renaissance Technologies LLC Sells 157,700 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Rhumbline Advisers - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Renaissance Technologies LLC Has $8.30 Million Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Sep 25, 2024
pulisher
Sep 23, 2024

Analytical Lens: Exploring ITeos Therapeutics Inc (ITOS)’s Financial Story Through Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 22, 2024

The week in pharma: action, reaction and insight – week to September 2024 | Pharmaceutical | The Pharmaletter - The Pharma Letter

Sep 22, 2024
pulisher
Sep 20, 2024

(ITOS) Investment Report - Stock Traders Daily

Sep 20, 2024
pulisher
Sep 20, 2024

Sept. 13-20 Undercovered Stock Picks: Aura Biosciences, APA Corporation, iTeos, CuriosityStream + - Seeking Alpha

Sep 20, 2024
pulisher
Sep 19, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Holdings Lifted by Victory Capital Management Inc. - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Bank of New York Mellon Corp Has $1.80 Million Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

JPMorgan maintains Overweight rating on iTeos amid TIGIT data By Investing.com - Investing.com Canada

Sep 19, 2024
pulisher
Sep 19, 2024

Wedbush Weighs in on iTeos Therapeutics, Inc.’s FY2027 Earnings (NASDAQ:ITOS) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

FY2027 Earnings Estimate for iTeos Therapeutics, Inc. Issued By Wedbush (NASDAQ:ITOS) - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

iTeos Therapeutics (NASDAQ:ITOS) Stock Rating Reaffirmed by HC Wainwright - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

View from ESMO: iTeos data keep TIGIT alive, for now - BioCentury

Sep 18, 2024

Iteos Therapeutics Inc Stock (ITOS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):